← Back to Analyst Consensus 
MDNAF Buy
Medicenna Therapeutics Corp.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Dec 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $2.5 | 44% |
| Dec 18, 2020 | Oppenheimer | initiate | — → Outperform | $12 | 52% |
| Dec 17, 2020 | Oppenheimer | initiate | — → Outperform | $12 | 52% |
| Sep 10, 2020 | HC Wainwright & Co. | initiate | — → Buy | $8 | 44% |
Price Target Trend
Apr 24, 2026 Latest: $4.25 Oct 23, 2026
EPS Estimates
+1y $-0.36
Lo: $-0.79 Hi: $-0.13
3 analysts ▲1
+1q $-0.04
Lo: $-0.04 Hi: $-0.04
2 analysts ▲1
0y $-0.16
Lo: $-0.16 Hi: $-0.15
2 analysts ▲2
0q $-0.04
Lo: $-0.04 Hi: $-0.04
2 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days